Posts tagged: Pfizer

Pfizer in talks to buy Seagen Inc for more than $30 billion, reveals the Wall Street Journal

Monday, 27 February 2023, 7:23 am

First they suggested it was Merck.

Now hacks at the Wall Street Journal claim Pfizer is in "ealy-stage" talks to buy Seagen, the US-listed biotechnology company worth more than $30 billion.

To be fair, the Wall Street Journal does report that Seagen's sale talks with Merck broke down last year.

Anyway a deal for Seagen appears to be back on. Below is a link to the WSJ scoop:..

Read more...

Deals, Deals, Deals ... in a bear market - Part 24

Monday, 8 August 2022, 6:43 pm

The US deal announcements are now arriving thick and fast.

Aside from the takeovers mentioned in this morning's note, Pfizer has announced it is buying Global Blood Therapeutics for $5.4 billion (confirming the Bloomberg and Wall Street Journal scoops from last week). Below is the link to the deal report from the WSJ:..

Read more...

UK dealmaking in the doldrums because of Brexit - perhaps not...

Wednesday, 19 December 2018, 1:19 pm

Typical!

Betaville was just in the process of liasing with one of the institutional data providers for the deals numbers for this quarter to prove my own theory that the volume of announced public transactions had fallen off cliff for this period compared to previous years when: boom - Pfizer and GlaxoSmithKline announce a £10billion merger of their respective consumer healthcare businesses. Below is a link to the news:..

Read more...

Shire said to edge closer to Radius deal - sources

Tuesday, 11 October 2016, 12:07 am

Shire is closing in on a multi-billion dollar takeover of US-listed Radius Health, a company that specialises in developing treatments for people with osteoporosis.

To be fair, rumours about Shire's interest in Radius are not particularly new. Talk of Shire pouncing on Radius, which currently has a market capitalisation of $2.2 billion, has been doing the rounds over the last twelve months...

Read more...